The Boston-based cardiac implant maker plans to begin analyzing trial data in April 2010, ahead of its fall target date, potentially setting the stage for a PMA application to the FDA in after the third quarter next year.
NMT Medical Inc. plans to begin analyzing the data from a clinical trial of its StarFlex cardiac implant ahead of schedule.
The Boston-based device maker said it will begin analyzing data from the CLOSURE I clinical trial of its StarFlex implant in April of next year, ahead of its fall 2010 target date.
InspireMD presents new 6 month follow-up data showing better survival rates for its MGuard stent
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
If you read nothing else today, make sure you're still in the know with MassDevice +3.